Latest Form 4 insider transactions
AMEX
CVM
Cel Sci CORPEyal Talor, Chief Scientific Officer of Cel Sci Corp, received 250,000 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPForm 4: Cel Sci CFO Receives Stock Grant
Patricia B Prichep, Chief Financial Officer of Cel Sci Corp, received 225,000 shares of common stock on August 14, 2026.
AMEX
CVM
Cel Sci CORPForm 4: Cel Sci CEO Receives Stock Grant
Geert R Kersten, Chief Executive Officer and a Director of Cel Sci Corp, received 300,000 shares of common stock on August 14, 2026.
NASDAQ
Franky Minnifield, a Director of Community Trust Bancorp Inc /Ky/, sold 3,900 shares of common stock on August 14, 2026 for $78.85 per share.
NYSE
AFL
Aflac INCForm 4: Aflac Insider Sells Shares
Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on August 13, 2026.
AMEX
Margaret Knight, a Director of Exodus Movement, Inc., sold 135 shares of common stock on August 3, 2026 for $5.11 per share.
NYSE
SMWB
Similarweb LTDForm 4: Similarweb CEO Sells Shares
Or Offer, Chief Executive Officer of Similarweb Ltd., sold 709,597 shares of common stock on August 13, 2026.
NASDAQ
NYAX
Nayax LTDForm 4: Nayax Director Sells Shares
Eran Havshush, a Director of Nayax Ltd., sold 20 shares of common stock on August 13, 2026 for $52.61 per share.
NASDAQ
Fulcrum Therapeutics and Slate Medicines are merging in an all-stock transaction, aiming to create a well-capitalized migraine-focused biotech company with a projected cash runway into 2029.
AMEX
HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.
HomeTrust Bancshares, Inc. announced a definitive merger agreement to acquire Blue Ridge Bankshares, Inc. in an all-stock transaction valued at approximately $448.1 million.
NASDAQ
Fulcrum Therapeutics and Slate Medicines announce a merger agreement, combining forces to advance Slate's migraine therapeutics pipeline, supported by a $245 million financing.
NASDAQ
CAMT
Camtek LTDForm 4: Camtek Director Sells Shares
Karni Yarl Andorn, a Director of Camtek Ltd, sold 5,532 shares of common stock on August 13, 2026.
Form 4: Issuer Direct CEO Buys Shares
Brian R Balbirnie, Director, CEO, a Director and 10% owner of Issuer Direct Corp, purchased 10,000 shares of common stock on August 14, 2026 for $4.95 per share.
NASDAQ
ACON
Aclarion, INCForm 4: Aclarion Director Buys Shares
Ryan Bond, a Director of Aclarion, Inc., purchased 21,122 shares of common stock on August 13, 2026 for $2.37 per share.
Wesley T Pollard, a Director of Issuer Direct Corp, purchased 2,000 shares of common stock on August 14, 2026 for $4.99 per share.
NASDAQ
ACON
Aclarion, INCForm 4: Aclarion Director Buys Shares
William Wesemann, a Director of Aclarion, Inc., purchased 2,150 shares of common stock on August 13, 2026 for $2.34 per share.
NASDAQ
ACON
Aclarion, INCForm 4: Aclarion Director Buys Shares
David K Neal, a Director of Aclarion, Inc., purchased 7,500 shares of common stock on August 13, 2026 for $2.40 per share.
NASDAQ
ACON
Aclarion, INCForm 4: Aclarion CEO Buys Shares
Brent Ness, Chief Executive Officer and a Director of Aclarion, Inc., purchased 5,234 shares of common stock on August 13, 2026 for $2.31 per share.
NASDAQ
Haris Fozan Basit, Chief Strategy Officer of Bitdeer Technologies Group, purchased 25,000 shares of common stock on August 14, 2026 for $8.84 per share.
NASDAQ
Shad Good, VP, Sales for North America of IceCure Medical Ltd., received 131,483 shares of common stock on August 14, 2026.
NYSE
Charles L Wilkins, Head of HSA Bank of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.
NYSE
ONON
On Holding AGForm 4: On Holding Executive Buys Shares
Olivier Bernhard, Executive Officer and a Director of On Holding AG, purchased 65,000 shares of common stock on August 14, 2026 for $30.67 per share.
NYSE
ONON
On Holding AGForm 4: On Holding Executive Buys Shares
Caspar Felix Coppetti, Executive Officer & Co-CEO and a Director of On Holding AG, purchased 65,000 shares of common stock on August 14, 2026 for $30.67 per share.
NYSE
Marissa Weidner, Chief Corp. Resp. Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Vikram A. Nafde, Chief Information Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Jason A. Soto, Chief Credit Officer of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Jason E. Schugel, Chief Risk Officer of Webster Financial Corp, reported a transaction in 830 shares of common stock on August 13, 2026.
NYSE
Luis Massiani, President and COO of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Christopher J Motl, President, Commercial Banking of Webster Financial Corp, reported multiple transactions in common stock on August 13, 2026.